Advance Pharmatech Drugs Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.19 M
- Company Age 20 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Ebitda
- Net Worth 9.62%
- Total Assets 10.67%
About Advance Pharmatech Drugs
Advance Pharmatech Drugs Private Limited (APDPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 September 2004 and has a history of 20 years and four months. Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.19 M, as per Ministry of Corporate Affairs (MCA) records.
Gayatri Gupta, Babu Gupta, Ramesh Gupta, and Three other members serve as directors at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232RJ2004PTC019749
-
Company No.
019749
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Sep 2004
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Advance Pharmatech Drugs?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Taru Saxena
|
Director | 28-Sep-2004 | Current |
|
Gayatri Gupta
|
Director | 06-Apr-2015 | Current |
|
Babu Gupta
|
Director | 06-Apr-2015 | Current |
|
Ramesh Gupta
|
Director | 06-Apr-2015 | Current |
|
Sudeep Jain
|
Director | 28-Sep-2004 | Current |
|
Sandeep Vijay
|
Director | 28-Sep-2004 | Current |
Financial Performance of Advance Pharmatech Drugs.
Advance Pharmatech Drugs Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 9.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Advance Pharmatech Drugs?
In 2018, Advance Pharmatech Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Anjani Medicos Private LimitedSandeep Vijay is a mutual person
-
Jaipur Laser Vision Centre Private Limited
Sandeep Vijay is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Advance Pharmatech Drugs?
Unlock and access historical data on people associated with Advance Pharmatech Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advance Pharmatech Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advance Pharmatech Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.